SEC Form 4 · accession 0001171843-19-000260
Zomedica Corp. · ZOMDF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephanie Morley
Officer — COO & VP of Product Dev
Period of report
Jan 10, 2019
Accepted (ET)
Jan 14, 2019 · 4:10 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001684144
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.52 | Jan 10, 2019 | A | 900,000 | A | Jan 10, 2019 | Jan 10, 2021 | Common Shares, without par value | 900,000 | 900,000 | D |
Explanation of responses
- F1The options vested upon grant. The option is currently fully vested.